Shanghai-based brain-computer interface (BCI) company StairMed, which claims to outperform Elon Musk’s Neuralink in certain ...

It’s Goosebumps for a new generation, and the fifth book, which is due for publication on August 5 this year, is titled The ...

We tried devices from Analan, ChomChom, Lilly Brush, and other brands to see which were best at dispatching cat and dog ...

Analysts have deemed LLY stock a “Strong Buy,” with an average target price of $984.29, indicating an upside potential of 12.1% from Friday’s closing price. Among the 24 analysts covering the stock, ...

Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment for diabetes and obesity.

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

They say good trips come to those who plan...OK, that's not how the saying goes, but you get the point. View Entire Post › ...

Wall Street drifted through a mixed day of trading as rising fashion and cigarette stocks worked against drops for Ford Motor ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...